China's Life Insurers Post 70% Profit Jump as Participating Policies Eclipse Traditional Guarantees

China's Participating Insurance Boom: A ¥1.01 Trillion Surge

Over the past three years, China's financial regulator has systematically dismantled the economics of traditional life insurance. The maximum guaranteed return on ordinary policies was cut in three steps—from 3.5% in August 2023 to 3.0%, then 2.5%, and finally 2.0% in September 2025. At the same time, a prolonged slide in market interest rates, with the 10-year government bond trading at just 1.725% at end‑June 2026, made those promises painfully expensive. The industry’s answer has been a dramatic pivot to participating (dividend) policies, locally known as fen hong xian, which combine a lower guaranteed rate with non‑guaranteed dividends linked to actual investment performance.

The numbers from the first half of 2026 show just how thoroughly the ground has shifted. China’s life insurers collected ¥28.72 trillion in total original premiums, a modest 3.6% year‑on‑year rise. But the breakout star was participating insurance, with premiums soaring 94.4% to ¥1.01 trillion. This was not merely steady migration; it was a stampede. Meanwhile, the six A‑share listed insurers reported combined net profits of approximately ¥304.07 billion, a jump of 70.6% from a year earlier. China Life alone guided for a net profit of ¥128.9‑137.1 billion, up 215‑235%.

However, the blistering growth was fueled in part by a regulatory deadline. From 1 July 2026, the cap on the assumed dividend rate used in product illustrations was cut from 3.9% to 3.5%, triggering a last‑minute rush to lock in the higher rate in June. That front‑loaded demand means the real, sustainable appetite for the new generation of policies will be revealed only in the second half of the year.

Inside the Insurers' Playbook: Lower Guarantees, Shorter Bonds, and a Stock Market Tailwind

Lower Guarantees, Fatter Margins—and a Stock Market Tailwind

The profit bonanza had two engines. The first was a robust rebound in the A‑share market during the second quarter, which lifted equity investment gains across the sector. The second, more structural, was the shrinking drag of guaranteed liabilities. Participating policies carry a guaranteed return cap of 1.75%—well below the 2.0% of traditional products—so the insurer’s fixed‑cost burden is smaller. When equity markets rise, that lower floor lets a larger share of investment gains flow straight to the bottom line. As a Shenwan Hongyuan research note put it, the mix shift created “greater tolerance for earnings flexibility.”

Shorter Bond Duration and the Reinvestment Gamble

The move to participating insurance is reshaping how insurers manage their colossal fixed‑income portfolios. According to Huachuang Securities’ fixed‑income chief Zhou Guannan, insurers have been buying bonds aggressively this year but are steering clear of ultra‑long maturities. In the secondary market they have been net sellers of government bonds, while the average duration of their local‑government bond purchases has drifted down from 20‑30 years to 15‑20 years. At the same time they are piling into 3‑5‑year credit bonds and tier‑2 capital instruments.

This “duration compression” is a direct consequence of the participating product design. The hot‑selling policies are predominantly fixed‑term annuities and endowment plans with shorter effective lifetimes than whole‑life contracts, and the annual cash dividend creates an early cash‑flow exit. Shorter liability duration forces shorter asset duration. The risk, however, is crystal clear: if the 10‑year yield continues to grind lower, the roll‑over of maturing 3‑5‑year paper into lower‑yielding instruments will steadily erode the fixed‑income return of the segregated dividend accounts—and with it, the very dividend achievement rates that policyholders are watching.

The Regulatory Trio That Unlocked the Equity Shift

Three policy measures, deliberately interlocking, have given insurers both the room and the incentive to lift equity allocations. In April 2025 the financial regulator raised the ceiling on equity investments to as high as 50% of total assets, tiered by solvency. In July 2025 the Ministry of Finance overhauled the performance evaluation of state‑owned insurers by blending the annual ROE target with three‑ and five‑year weighted returns, with long‑cycle indicators carrying 70% of the weight. Then in April 2026 the securities regulator confirmed that insurance funds could enter private placements as strategic investors. The result: China Life alone held more than ¥1.3 trillion in onshore public‑market equities by end‑June 2026, and the regulator has approved a total of ¥222 billion in long‑term investment pilot quotas across three rounds.

Winners, Consolidation, and the Flight‑Risk Clock

The shift is concentrating clout among the largest players. Hua Chuang data shows that China Life and New China Life have moved decisively into consumer and financial blue chips—Kweichow Moutai, Wuliangye, ICBC—while trimming cyclical holdings such as Shaanxi Coal. The combined might of these trillion‑yuan portfolios is turning insurers from passive participants into market‑moving forces.

But the model’s sturdiness rests on one fragile metric: the dividend achievement rate. Data compiled by Securities Daily from 714 participating products in 2025 showed rates ranging from 0% to 166%, with about 70% of products delivering actual dividends below their illustration levels. If that under‑delivery persists or worsens, a wave of policyholder surrenders—and the accompanying reputational damage—becomes a live risk. The 94.4% premium surge already blends two very different forces: an enduring trend toward lower‑guarantee products, and a one‑time regulatory‑deadline sprint. The second half of 2026 will be the true gauge of demand.

What Executives, Investors and Policyholders Should Do Now

The new insurance landscape demands a recalibration of strategies for three distinct groups:

• Insurance executives: Stress‑test the investment portfolio under a scenario where the 10‑year yield slips to 1.5% and credit spreads widen by 50 basis points. With the heavy tilt toward 3‑5‑year credit bonds documented by Huachuang Securities, a sudden repricing would hit both the general account and the segregated dividend accounts, directly threatening dividend achievement rates and future sales. Revisit asset‑liability matching models to account for the shorter effective duration of newly issued participating products.
• Investors: The 70%+ profit surge is unlikely to be repeated unless equity markets deliver another double‑digit quarter. Focus instead on two leading indicators: the quarterly disclosure of dividend achievement rates from major insurers, and the post‑July‑2026 participating premium run‑rate. A sharp slowdown in premium growth combined with a drop in achievement rates would signal a correction in insurer valuations.
• Policyholders: Participating products are not a proxy for a bank deposit. The guaranteed portion is capped at 1.75% and the non‑guaranteed dividend can be zero. Before purchasing, check the product’s historical achievement rate using the insurer’s mandatory disclosures. With 70% of products underperforming their illustrations last year, a margin of safety is essential. Treat any dividend above the guarantee as a potential upside, not a promise.
• Regulators: The shift transfers interest‑rate and investment risk onto retail policyholders. The China Banking and Insurance Regulatory Commission should accelerate efforts to standardise dividend‑illustration assumptions and introduce a uniform solvency‑stress scenario that reflects the shorter liability duration, to ensure that capital buffers are adequate for the new product mix.